Erschienen in:
01.12.2011 | Erratum
Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
verfasst von:
Philip Q. Bao, MD, Ramesh K. Ramanathan, MD, Alyssa Krasinkas, MD, Nathan Bahary, MD, Barry C. Lembersky, MD, David L. Bartlett, MD, Steven J. Hughes, MD, Kenneth K. Lee, MD, A. James Moser, MD, Herbert J. Zeh III, MD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2011
Einloggen, um Zugang zu erhalten
Excerpt
The article entitled, “Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer” by Bao et al (Ann Surg Oncol [2011] 18:1122–1129 DOI
10.1245/s10434-010-1401-9) did not correctly identify the two corresponding authors. …